PMC Links for Books (Select 4856050) - PMC

Select item 56184481.

Fatal Acute Liver Failure as a Consequence of Regorafenib Treatment in a Metastatic Colon Cancer

Dominique Béchade, Marie Desjardin, Claire Castain, Pierre-Henri Bernard, Marianne Fonck

Case Rep Oncol. 2017 May-Aug; 10(2): 790–794. Published online 2017 Aug 29. doi: 10.1159/000479732

PMCID:: PMC5618448

Abstract Article PDF–984K

Select item 54060552.

Unexpected side effect in mCRC: A care-compliant case report of regorafenib-induced hyperammonemic encephalopathy

Michela Quirino, Sabrina Rossi, Giovanni Schinzari, Michele Basso, Antonia Strippoli, Alessandra Cassano, Carlo Barone

Medicine (Baltimore) 2017 Apr; 96(16): e6522. Published online 2017 Apr 21. doi: 10.1097/MD.0000000000006522

PMCID:: PMC5406055

Abstract Article PDF–200K

Select item 52449013.

Pseudocirrhosis caused by regorafenib in an advanced rectal cancer patient with multiple liver metastases

Kensuke Kumamoto, Shungo Endo, Noriyuki Isohata, Azuma Nirei, Daiki Nemoto, Kenichi Utano, Takuro Saito, Kazutomo Togashi

Mol Clin Oncol. 2017 Jan; 6(1): 63–66. Published online 2016 Nov 28. doi: 10.3892/mco.2016.1096

PMCID:: PMC5244901

Abstract Article PDF–399K

Select item 49361934.

Survival, safety, and prognostic factors for outcome with Regorafenib in patients with metastatic colorectal cancer refractory to standard therapies: results from a multicenter study (REBACCA) nested within a compassionate use program

Antoine Adenis, Christelle de la Fouchardiere, Bernard Paule, Pascal Burtin, David Tougeron, Jennifer Wallet, Louis-Marie Dourthe, Pierre-Luc Etienne, Laurent Mineur, Stéphanie Clisant, Jean-Marc Phelip, Andrew Kramar, Thierry Andre

BMC Cancer. 2016; 16: 412. Published online 2016 Jul 7. doi: 10.1186/s12885-016-2440-9

Correction in:: BMC Cancer. 2016; 16: 518.

PMCID:: PMC4936193

Abstract Article PDF–705K

Select item 48807625.

Regorafenib could cause sinusoidal obstruction syndrome

Motoi Takahashi, Shigeru Harada, Hideo Suzuki, Naoki Yamashita, Hiroyuki Orita, Masaki Kato, Kazuhiro Kotoh

J Gastrointest Oncol. 2016 Jun; 7(3): E41–E44. doi: 10.21037/jgo.2015.11.01

PMCID:: PMC4880762

Abstract Article PDF–849K

Select item 47271956.

Immunosuppressant therapy successfully improved regorafenib-induced severe hepatic injury in a patient with metastatic gastrointestinal stromal tumor: A case report

MIYUKI KUWAYAMA, KEITA UCHINO, KOTOE TAKAYOSHI, MASATO KOMODA, MOTOYUKI KOHJIMA, MAKOTO NAKAMUTA, SEIYA MOMOSAKI, HITOSHI KUSABA, KOICHI AKASHI, EISHI BABA

Oncol Lett. 2016 Jan; 11(1): 85–88. Published online 2015 Nov 2. doi: 10.3892/ol.2015.3853

PMCID:: PMC4727195

Abstract Article PDF–580K

Select item 45931997.

Acute liver failure and seizures as a consequence of regorafenib exposure in advanced rectal cancer

Soundouss Raissouni, Zarqa Quraishi, Mohammed Al-ghamdi, Jose Monzon, Patricia Tang, Michael M. Vickers

BMC Res Notes. 2015; 8: 538. Published online 2015 Oct 5. doi: 10.1186/s13104-015-1502-4

PMCID:: PMC4593199

Abstract Article PDF–822K

Select item 44462358.

Features and Outcomes of 899 Patients with Drug-induced Liver Injury: The DILIN Prospective Study

N Chalasani, HL Bonkovsky, R Fontana, W Lee, A Stolz, J Talwalkar, KR Reddy, PB Watkins, V Navarro, H Barnhart, J Gu, J Serrano, for the United States Drug Induced Liver Injury Network

Gastroenterology. Author manuscript; available in PMC 2016 Jun 1.

Published in final edited form as: Gastroenterology. 2015 Jun; 148(7): 1340–1352.e7. Published online 2015 Mar 6. doi: 10.1053/j.gastro.2015.03.006

PMCID:: PMC4446235

Abstract Article PDF–546K

Select item 44444399.

Hepatotoxicity of molecular targeted therapy

Bożenna Karczmarek-Borowska, Agata Sałek-Zań

Contemp Oncol (Pozn) 2015; 19(2): 87–92. Published online 2014 Aug 29. doi: 10.5114/wo.2014.43495

PMCID:: PMC4444439

Abstract Article PDF–72K

Select item 409391810.

Incidence and relative risk of hepatic toxicity in patients treated with anti-angiogenic tyrosine kinase inhibitors for malignancy

Roberto Iacovelli, Antonella Palazzo, Giuseppe Procopio, Matteo Santoni, Patrizia Trenta, Angelina De Benedetto, Silvia Mezi, Enrico Cortesi

Br J Clin Pharmacol. 2014 Jun; 77(6): 929–938. Published online 2013 Aug 28. doi: 10.1111/bcp.12231

PMCID:: PMC4093918

Abstract Article PDF–1003K

Select item 391384411.

Prevention and management of adverse events related to regorafenib

Mieke De Wit, Christine B. Boers-Doets, Alessandra Saettini, Kristina Vermeersch, Carmen Roncero de Juan, Jan Ouwerkerk, See-See Raynard, Ashley Bazin, Chiara Cremolini

Support Care Cancer. 2014; 22(3): 837–846. Published online 2013 Dec 14. doi: 10.1007/s00520-013-2085-z

PMCID:: PMC3913844

Abstract Article PDF–318K

Select item 381994212.

Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib: an international, multicentre, prospective, randomised, placebo-controlled phase 3 trial (GRID)

George D Demetri, Peter Reichardt, Yoon-Koo Kang, Jean-Yves Blay, Piotr Rutkowski, Hans Gelderblom, Peter Hohenberger, Michael Leahy, Margaret von Mehren, Heikki Joensuu, Giuseppe Badalamenti, Martin Blackstein, Axel Le Cesne, Patrick Schöffski, Robert G Maki, Sebastian Bauer, Binh Bui Nguyen, Jianming Xu, Toshirou Nishida, John Chung, Christian Kappeler, Iris Kuss, Dirk Laurent, Paolo Casali, on behalf of all GRID study investigators

Lancet. Author manuscript; available in PMC 2013 Nov 7.

Published in final edited form as: Lancet. 2013 Jan 26; 381(9863): 10.1016/S0140-6736(12)61857-1. Published online 2012 Nov 22. doi: 10.1016/S0140-6736(12)61857-1

PMCID:: PMC3819942

Abstract Article PDF–2.2M

Select item 367569513.

Efficacy and Safety of Regorafenib in Patients With Metastatic and/or Unresectable GI Stromal Tumor After Failure of Imatinib and Sunitinib: A Multicenter Phase II Trial

Suzanne George, Qian Wang, Michael C. Heinrich, Christopher L. Corless, Meijun Zhu, James E. Butrynski, Jeffrey A. Morgan, Andrew J. Wagner, Edwin Choy, William D. Tap, Jeffrey T. Yap, Annick D. Van den Abbeele, Judith B. Manola, Sarah M. Solomon, Jonathan A. Fletcher, Margaret von Mehren, George D. Demetri

J Clin Oncol. 2012 Jul 1; 30(19): 2401–2407. Published online 2012 May 21. doi: 10.1200/JCO.2011.39.9394

PMCID:: PMC3675695

Abstract Article PDF–300K

PMC

Result Filters

Article attributes

Text availability

Publication date

Custom date range

Research Funder

Additional filters

Display Settings:

Send to:

Links from Books

Items: 13

Display Settings:

Send to:

Supplemental Content

Find related data

Recent activity